<DOC>
	<DOC>NCT00742469</DOC>
	<brief_summary>The purpose of this study is to determine if 600 mg of rifaximin, taken once a day for 14 days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea compared to placebo.</brief_summary>
	<brief_title>Rifaximin for Prevention of Travellers' Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>1. travelling to Mexico within 72 hours of enrollment 2. read and understand English 3. in good health 1. acute diarrhea within previous 7 days 2. taken FQs (any drug in this class), macrolide, azalide, or trimethoprimsulfamethoxazole within 7 days or enrollment or anytime during study. 3. taken antidiarrheal medication within 24 hours of enrollment or anytime during study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>TD</keyword>
	<keyword>traveller's diarrhea</keyword>
	<keyword>campylobacter</keyword>
	<keyword>shigella</keyword>
	<keyword>salmonella</keyword>
	<keyword>E. coli</keyword>
	<keyword>diarrhea</keyword>
</DOC>